Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Happiness Biotech Group Limited Announces Name Change to Happiness Development Group Limited and Re-Designation of Its Ordinary Shares 2021-11-11 21:00
Hummingbird Bioscience Announces Trials in Progress Poster Presentation at the Society for Immunotherapy of Cancer 2021 36th Annual Meeting 2021-11-10 17:00
I-Mab and ABL Bio Report Preclinical Data of 4-1BB-targeting Bispecific Antibodies at 2021 SITC 2021-11-09 21:05
Alterity Therapeutics Announces Presentation of ATH434 at the American Autonomic Society Virtual Meeting 2021 2021-11-09 20:30
InnoRNA of China participates in the Hanmi Science Consortium …"To join forces to eliminate 'vaccine divide'" 2021-11-09 14:20
InnoCare to Present Orelabrutinib Data at the Upcoming 63rd Annual Meeting of ASH 2021-11-09 13:06
Standigm Established a Synthetic Research Center to Improve Efficiency of AI Drug Discovery 2021-11-09 10:47
BIORCHESTRA will present data on the therapeutic efficacy of their proprietary ASO against pathological miRNA, a key modulator of neuroinflammation and neurodegeneration, at the CTAD Meeting in Boston 2021-11-08 22:59
Ascentage Pharma Announces Clinical Trial Agreement to Evaluate the Combination of Lisaftoclax (APG-2575) and the CDK4/6 Inhibitor IBRANCE® (Palbociclib) in Metastatic ER+/HER2- Breast Cancer 2021-11-08 21:47
Farmmi Announces Latest Multi-Product Sales Win 2021-11-08 21:00
Everest Medicines Announces Up to HK$100 million Additional Share Repurchase Program 2021-11-08 08:10
PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline 2021-11-05 20:37
Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting 2021-11-04 21:05
I-Mab to Present Clinical Data of Lemzoparlimab in Combination with Rituximab in Non-Hodgkins's Lymphoma at ASH 2021 2021-11-04 21:00
Taizhou, China: Building a Famous Chinese Medical City with Efforts 2021-11-04 20:16
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases 2021-11-04 19:30
Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX 2021-11-03 22:00
Standigm Files PCT Patent Application of AI-driven Repurposed Drugs for Primary Mitochondrial Disease 2021-11-03 21:00
Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021 2021-11-03 15:00
Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi Science Consortium and invites other groups to join 2021-11-03 12:28
1 135 136 137 138 139 261